【摘要】：目的:為政府部門制訂藥品賦碼政策提供數(shù)據(jù)支持,保證用藥安全。方法:調(diào)研我院現(xiàn)有的1 297個品規(guī)的藥品最小外包裝上條形碼、電子監(jiān)管碼的賦碼情況,分別按藥品制造商類型(進口、進口分裝、國產(chǎn))和處方類型(處方藥與非處方藥)進行調(diào)研、分類與分析。結(jié)果:我院現(xiàn)有藥品中有條形碼、有電子監(jiān)管碼、兩碼兼有以及兩碼均無的藥品分別占總品規(guī)的50.27%、37.24%、20.28%和32.77%;進口藥品中上述情況分別占23.21%、4.29%、0.71%、73.21%,進口分裝類藥品中則分別為30.22%、44.60%、12.95%、38.13%,國產(chǎn)藥品為62.07%、46.58%、27.68%、19.02%;處方藥中上述情況分別占44.39%、36.95%、18.21%和36.87%,非處方藥中則分別為93.55%、39.35%、35.48%和2.58%。結(jié)論:在調(diào)查的藥品中,條形碼較電子監(jiān)管碼賦碼率相對更高,非處方藥較處方藥賦碼率更高。建議加快賦碼速度、統(tǒng)一賦碼標準,以利于實現(xiàn)藥品的科學化管理,確保患者安全用藥。
[Abstract]:Objective: to provide data support for government departments to formulate drug coding policy to ensure drug safety. Methods: to investigate the barcode and electronic regulatory code on the minimum outer package of 1 297 products in our hospital, and divide them according to the type of drug manufacturer (import and import). Domestic) and prescription types (prescription and OTC) were investigated, classified and analyzed. Results: there were bar codes and electronic regulatory codes in the existing drugs in our hospital. The number of drugs in both yards and without them accounted for 50.27.2% and 32.77% of the total specifications, respectively; the proportion of imported drugs was 23.2121 and 4.294.294.290.771.The number was 30.222.6012.958.13. the number of domestic drugs was 62.0776.587.6819.022.The proportion of prescription drugs was 44.3936.9518.21% and 36.87g respectively. The proportion of non-prescriptions was 36.9518.21% and 36.87g respectively. The proportion of domestic drugs was 62.07 and 27.6819.02.The proportion of prescriptions was 44.3936.9518.21% and 36.87g respectively. In prescription drugs 93.55% and 2.58%, respectively. Conclusion: among the drugs investigated, the rate of barcode is higher than that of electronic regulatory code, and the rate of over-the-counter drugs is higher than that of prescription drugs. It is suggested to speed up the coding speed and unify the coding standard in order to realize the scientific management of drugs and ensure the safe use of drugs for patients.
【作者單位】： 中國醫(yī)學科學院/北京協(xié)和醫(yī)學院北京協(xié)和醫(yī)院藥劑科;北京中醫(yī)藥大學東直門醫(yī)院東區(qū)藥劑科;
【基金】：北京市2013-2014年度國家臨床重點�？平ㄔO項目——信息化藥品管理體系建設
【分類號】：R95

【共引文獻】

相關期刊論文 前3條

1 鄭敏霞;;中成藥編碼研究[J];海峽藥學;2011年05期

2 徐s，

本文編號：2217184